3836 NEW ZEALAND GAZETTE, No. 141 18 SEPTEMBER 2008

Intellectual Disability (Compulsory Care and Rehabilitation) Act 2003

Appointment of Compulsory Care Co-ordinator

Under section 140 of the Intellectual Disability (Compulsory Care and Rehabilitation) Act 2003, I appoint the following person as a compulsory care co-ordinator for the named geographical and operational areas listed below.

Southern region, being the geographical area including the whole of the South Island:

Lynette Stenning

The appointment of the above-named person takes effect on the date this notice is published in the New Zealand Gazette and ends on 25 August 2013.

Dated at Wellington this 25th day of August 2008.

STEPHEN MCKERNAN, Director-General of Health.

go6807

Appointment of Compulsory Care Co-ordinator

Under section 140 of the Intellectual Disability (Compulsory Care and Rehabilitation) Act 2003, I appoint the following person as a compulsory care co-ordinator for the named geographical and operational areas listed below.

Southern region, being the geographical area including the whole of the South Island:

Yestin Spowart

The appointment of the above-named person takes effect on the date this notice is published in the New Zealand Gazette and ends on 25 August 2013.

Dated at Wellington this 25th day of August 2008.

STEPHEN MCKERNAN, Director-General of Health.

go6806

Medicines Act 1981

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Noxafil
Active Ingredient: Posaconazole 40mg/mL
Dosage Form: Oral suspension
New Zealand Sponsor: Schering-Plough a division of Schering-Plough Animal Health Limited
Manufacturer: Patheon Inc, Whitby Operations, Whitby, Ontario, Canada

Product: Strepfen Intensive Orange Sugar Free
Active Ingredient: Flurbiprofen 8.75mg
Dosage Form: Lozenge
New Zealand Sponsor: Reckitt Benckiser (New Zealand) Limited
Manufacturer: Reckitt Benckiser Healthcare International Limited, Nottingham, Nottinghamshire, United Kingdom

Product: Tatig
Active Ingredient: Sertraline hydrochloride 111.9mg equivalent to 100mg sertraline
Dosage Form: Film coated tablet
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturers: Pfizer Australia Pty Limited, West Ryde, New South Wales, Australia
Pfizer Italia Srl, Borgo San Michele, Latina, Italy
Pfizer Pharmaceuticals Limited, Economic and Technical, Development Zone, Dalian, China

Product: Tatig
Active Ingredient: Sertraline hydrochloride 55.95mg equivalent to 50mg sertraline
Dosage Form: Film coated tablet
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturers: Pfizer Australia Pty Limited, West Ryde, New South Wales, Australia
Pfizer Italia Srl, Borgo San Michele, Latina, Italy
Pfizer Pharmaceuticals Limited, Economic and Technical, Development Zone, Dalian, China

Dated this 12th day of September 2008.

ANTHONY HILL, Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).

go6871

Consent to the Distribution of a Changed Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the following new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto: